Continuous Glucose Monitoring (CGM) Sensors Market worth $ 11.7 Billion by 2028

Insightace Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Continuous Glucose Monitoring (CGM) Sensors Market- by Products (Non-invasive Sensing and Minimally Invasive Sensing), Sensing Technology (Enzyme Electrode, Optical Fluorescence and Others), End-Users (Hospitals and Home care, Specialty Clinics, Ambulatory Settings and Others), Patient Population (Children and Teenagers and Adults), Sensor Sites (Abdomen, Upper Arm (implanted), Back of Upper Arms and Other (Abdomen and Buttocks)), Trends, Industry Competition Analysis, Revenue and Forecast To 2028."

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1181

According to the latest research by Insightace Analytics, the global Continuous Glucose Monitoring (CGM) Sensors market was valued at US$ 3.6 Billion in 2021. It is expected to reach US$ 11.7 Billion by 2028, with a CAGR of 18 % during a forecast period of 2022-2028.

Diabetes is a complicated, long-term illness requiring constant medical treatment, varied risk-reduction strategies, and glucose management. Diabetes is a severe health problem among the elderly; around one-quarter of people over 65 have diabetes, which is expected to skyrocket in the next decades. Continuous glucose monitoring devices aid in the detection of high blood glucose levels. CGM systems are the most effective method of controlling and managing diabetes. These devices provide patients with various information, including meal specifics, time reminders, medicine, physical activity, and disease information, and may reduce errors in manual glucose monitoring. It is a valuable technique in diabetes care for persons with type 1. It is type 2 diabetes because it provides a complete picture of their glucose levels at critical periods throughout the day, such as when driving, before and during exercise, taking a test or exam, and in the middle of the night.

A rise in Type 1 and Type 2 diabetes incidence, greater sensor device adoption, technological developments in diabetic devices, and increased funding for diabetes are all expected to drive the market. A continuous glucose monitoring device can help patients manage and control their illness. Therefore, a continuous glucose monitoring device can assist those with diabetes types 1 and 2 receive the necessary care. Wearable medical devices are predicted to be widely used during the projection period, and advancements in wireless technology for CGM sensors are anticipated to open up several promising opportunities. In the upcoming years, it is anticipated that the miniaturization of electrochemical-based implanted CGM systems will present profitable growth prospects. The COVID-19 epidemic significantly impacts continuous Glucose Monitoring (CGM) Sensors. According to a research paper published in Diabetes Care Journal in November 2020, the COVID-19 epidemic has increased the urgency of the necessity to look into the viability of CGM in the hospital to protect personal protective equipment (PPE) and lower health care workers' exposure.

North America is anticipated to majorly contribute to the Continuous Glucose Monitoring (CGM) Sensors market over the forecast years because of the healthcare industry's early adoption of emerging technologies. The rapid development in product innovation and the expanding demand for these CGM systems in diabetes treatment are also driving global product demand. In addition, the Asia Pacific Continuous Glucose Monitoring (CGM) Sensors market is expected to grow significantly during the forecast period because of the availability of a diversified patient pool, developing economies, and increased collaboration between domestic and international efforts in these countries, driving this market.

Request for ToC/Proposal:
Major market players operating in the Continuous Glucose Monitoring (CGM) Sensors market include

Medtronics, Abbott, Senseonics, WaveForm Technologies, Inc., Advanced Biosensors-Ohio LLC, Arkal Medical, Inc., Ascensia Diabetes Care Holdings AG, Azurite Technologies, Inc., Biorasis Inc, Biovotion AG, CALISTO MEDICAL, INC., CGM3 Ltd, ConvaTec Group Plc, Cyber Medical Ltd, Debiotech SA, DexCom Inc, DirectSens GmbH, Echo Therapeutics Inc, Ecole Polytechnique Federale de Lausanne, eLutions Integrated Systems, Inc., EyeSense GmbH, Flowsion A/S, Gili Medical Ltd, Globe Medical Tech Inc, GlucoLight Corporation, Glucometrix AG, Glucosense Diagnostics Ltd, GlucoSet AS, Glucovation Inc, GluMetrics Inc, Glusense Ltd, GlySens Inc, Glysure Ltd, G-Sense Ltd., iGlyko, Inc., Indigo Diabetes NV, Innovosens AB, Insulet Corp, Integrated Medical Sensors, Integrity Applications Ltd, Invivosense ASA, I-Sens Inc, iSense Corporation, Keratin Biosciences Inc, Kiffik Biomedical inc., LEMM Technologies, LLC, Mellitor Ltd, Metronom Health Inc, mobiLIFE, Nemaura Medical Inc, Newton Photonics Inc, Orsus Medical Ltd, PKvitality, PositiveID Corp, Prediktor Medical AS, Profusa Inc, Purdue University, San Meditech (Huzhou) Co., Ltd., Senseonics Holdings Inc, SensiVida Medical Technologies, Inc., Senzime AB, Singapore Biomicro Pte Ltd, Socrates Health Solutions, Inc., Tenax Therapeutics Inc, VeriTeQ Corporation, Vytrace, Inc., and Other Prominent Players.

Recent collaborations and agreements in the market:
In May 2021, Medtronic achieved CE clearance for prolonged use of its InPen smart insulin pen for multiple daily injections (MDI) and its Guardian 4 sensor for enhanced diabetes management.
In November 2020, according to a recent announcement from Abbott, women in India who have gestational diabetes (diabetes during pregnancy) and adults and children (over the age of four) who have diabetes now have access to the FreeStyle Libre system, continuous glucose monitoring (CGM) technology, allowing them to check their blood sugar levels at any time.

Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1181

Market Segments
Global Continuous Glucose Monitoring (CGM) Sensors Market, by Products, 2022-2028 (Value US$ Mn)
Non-invasive Sensing
Minimally Invasive Sensing

Global Continuous Glucose Monitoring (CGM) Sensors Market, by Sensing Technology, 2022-2028 (Value US$ Mn)
Enzyme Electrode
Optical Fluorescence
Others

Global Continuous Glucose Monitoring (CGM) Sensors Market, by End-Users, 2022-2028 (Value US$ Mn)
Hospitals and Home care
Specialty Clinics
Ambulatory Settings
Others

Global Continuous Glucose Monitoring (CGM) Sensors Market, by Patient Population, 2022-2028 (Value US$ Mn)
Children and Teenagers
Adults

Global Continuous Glucose Monitoring (CGM) Sensors Market, by Sensor Sites, 2022-2028 (Value US$ Mn)
Abdomen
Upper Arm (implanted)
Back of Upper Arm
Other (Abdomen and Buttocks)

Global Continuous Glucose Monitoring (CGM) Sensors Market, by Region, 2022-2028 (Value US$ Mn)
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

North America Continuous Glucose Monitoring (CGM) Sensors Market, by Country, 2022-2028 (Value US$ Mn)
U.S.
Canada

Europe Continuous Glucose Monitoring (CGM) Sensors Market, by Country, 2022-2028 (Value US$ Mn)
Germany
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific Continuous Glucose Monitoring (CGM) Sensors Market, by Country, 2022-2028 (Value US$ Mn)
India
China
Japan
South Korea
Australia & New Zealand

Latin America Continuous Glucose Monitoring (CGM) Sensors Market, by Country, 2022-2028 (Value US$ Mn)
Brazil
Mexico
Rest of Latin America

Middle East & Africa Continuous Glucose Monitoring (CGM) Sensors Market, by Country, 2022-2028 (Value US$ Mn)
GCC Countries
South Africa
Rest of Middle East & Africa

Why should buy this report:
To receive a comprehensive analysis of the prospects for the global Continuous Glucose Monitoring (CGM) Sensors market
To receive an industry overview and future trends of the Continuous Glucose Monitoring (CGM) Sensors market
To analyze the Continuous Glucose Monitoring (CGM) Sensors market drivers and challenges
To get information on the Continuous Glucose Monitoring (CGM) Sensors market value (US$Mn) forecast to 2028
Significant investments, mergers & acquisitions in the Continuous Glucose Monitoring (CGM) Sensors market industry

For More Information @ https://www.insightaceanalytic.com/customisation/1181

Corporate Office :
Office No.3050, 3rd Floor Marvel Fuego, Magarpatta Rd, Hadapsar, Pune, Maharashtra 411028

Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com

info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118

This release was published on openPR.